Skip to main content
. 2019 Jun 11;7:e7070. doi: 10.7717/peerj.7070

Table 1. Clinical characteristics of the liver cancer patients.

Characteristics Number of patients(%)
Age
<55 117(31.45)
≥55 255(68.55)
Gender
FEMALE 121(32.44)
MALE 252(67.56)
histological_type
Fibrolamellar Carcinoma 3(0.8)
Hepatocellular Carcinoma 363(97.32)
Hepatocholangiocarcinoma (Mixed) 7(1.88)
histologic_grade
NA 5(1.34)
G1 55(14.75)
G2 178(47.72)
G3 123(32.98)
G4 12(3.22)
Stage
NA 24(6.43)
I 172(46.11)
II 87(23.32)
III 85(22.79)
IV 5(1.34)
T_classification
NA 2(0.54)
T1 182(48.79)
T2 95(25.47)
T3 80(21.45)
T4 13(3.49)
TX 1(0.27)
N_classification
NA 1(0.27)
N0 253(67.83)
N1 4(1.07)
NX 115(30.83)
M_classification
M0 267(71.58)
M1 4(1.07)
MX 102(27.35)
radiation_therapy
NA 25(6.7)
NO 340(91.15)
YES 8(2.14)
residual_tumor
NA 7(1.88)
R0 326(87.4)
R1 17(4.56)
R2 1(0.27)
RX 22(5.9)
Vital_status
DECEASED 130(34.85)
LIVING 243(65.15)
Relapse
NO 179(55.94)
YES 141(44.06)
PGM5
High 165(44.24)
Low 208(55.76)